QSS
INSM icon

Quantitative Systematic Strategies’s Insmed INSM Stock Holding History

Quantitative Systematic Strategies’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-7,880
Closed -$268K – 559
2021
Q1 		$268K Buy
+7,880
New +$301K 0.04% 495
2020
Q1 		– Sell
-14,271
Closed -$341K – 387
2019
Q4 		$341K Buy
+14,271
New +$290K 0.05% 421

Other funds holding INSM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Quantitative Systematic Strategies's INSM Position: Q2 2021 in Review

Quantitative Systematic Strategies sold out of Insmed (INSM) in Q2 2021, closing a stake of 7,880 shares — an estimated $268K sold.

Quantitative Systematic Strategies first reported a position in INSM in Q4 2019 and held it in 2 quarters. The position peaked at $341K in Q4 2019. 203 funds tracked by Wall St. Rank hold INSM as of Q2 2021.

  • Quantitative Systematic Strategies reported no remaining Insmed position as of Q2 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 7,880 Insmed shares in Q2 2021, an estimated $268K.
  • Quantitative Systematic Strategies first reported a position in Insmed in Q4 2019 and held it in 2 quarters.
  • Quantitative Systematic Strategies's Insmed position peaked at $341K in Q4 2019.
  • 203 funds tracked by Wall St. Rank held Insmed as of Q2 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q2 2021, filed 5 Aug 2021.